Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00472264 · ClinicalTrials.gov registry record
A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 20
- Enrollment target
NCT00472264 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 20 participants.
The verdict
NCT00472264 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
It is hypothesised that there is a difference between the uptake of a radioactive substance (\[18F\]fluorodeoxyglucose (FDG)) in the lungs of patients with Chronic Obstructive Pulmonary Disease (COPD) and healthy volunteers.
Interventions
- PROCEDURE PET imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00472264
The ClinicalTrials.gov registry entry for NCT00472264 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET imaging is the first listed.
NCT00472264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00472264 about?
NCT00472264 is a clinical study titled "A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients". It is hypothesised that there is a difference between the uptake of a radioactive substance (\[18F\]fluorodeoxyglucose (FDG)) in the lungs of patients with Chronic Obstructive Pulmonary Disease (COPD) and healthy volunteers.
What is the current status of trial NCT00472264?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2007-05. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00472264?
The interventions under investigation include: PET imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00472264?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.